Pegylated Liposomal Doxorubicin Confers a High Risk for Pneumocystis Jirovecii Pneumonia in Patients With Diffuse Large B-Cell Lymphoma

Siqian Wang(Shandong University), Shujuan Zhou(Shanghai Medical College of Fudan University), Songfu Jiang(Wenzhou Medical University), Haige Ye(Wenzhou Medical University), Sun Lan(Wenzhou Medical University), Honglan Qian(Wenzhou Medical University), Yongyong Ma(Wenzhou Medical University), Liyuan Tang(Wenzhou Medical University), Xi Xu(Wenzhou Medical University), Zhijian Shen(Wenzhou Medical University), Shanhu Qian(First Affiliated Hospital of Wenzhou Medical University)
Clinical Therapeutics
August 7, 2025
10.1016/j.clinthera.2025.06.016
Cited by 0

Related Papers

Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma
|BioMed Research International|2018|50
MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia
|Oncology Letters|2018|46
Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma
|Blood|2019|40
Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma
|Blood|2020|36
Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients
|Oncotarget|2017|29